跳至主要内容
临床试验/TCTR20221206005
TCTR20221206005尚未招募3 期

Efficacy and safety of Acetaminophen in Delayed knee joint replacement osteoarthritic patients during COVID-19 pandemic : A double-blind randomized placebo controlled trial study

avamindradhiraj university0 个研究点目标入组 196 人开始时间: 2022年12月6日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
196

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 Years 至 75 Years(—)
性别
All

入选标准

  • Primary knee osteoarthritis 50-75 years old indicating for knee replacement with Chronic mild to moderate knee pain with Kellgren-Lawrence III-IV

排除标准

  • Flare-up knee osteoarthritis
  • Inflammatory arthritis
  • History of knee trauma or surgery
  • Contraindication for Acetaminophen, Naproxen and Omeprazole
  • Other indications for analgesic drugs
  • Severe pain in knee osteoarthritis

研究者

发起方
avamindradhiraj university

相似试验

Efficacy and safety of Acetaminophen in Delayed knee... | 临床试验